METASTATIC CHOLANGIOCARCINOMA
Clinical trials for METASTATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bile duct cancer: targeted drug trial launches
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 15 people with advanced bile duct cancer that has spread or come back. The drug works like a smart bomb, attaching to a protein on cancer cells and delivering a toxic payload to kill them. The main goal is to see how many pa…
Matched conditions: METASTATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Triple attack on tough tumors: drug combo plus radiation shows promise
Disease control OngoingThis study tests a combination of two drugs (peposertib and avelumab) plus a special type of radiation for people with advanced solid tumors or bile duct cancers that have spread. The goal is to find the best dose and see if the treatment can shrink tumors or stop them from growi…
Matched conditions: METASTATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New combo shows promise against tough liver cancer
Disease control OngoingThis study tests a new drug called pevonedistat, given alone or with standard chemotherapy, in 40 adults with advanced bile duct cancer that has spread or cannot be removed. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must have …
Matched conditions: METASTATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:59 UTC